Skip to main content
Log in

Kinetics of cotinine after oral and intravenous administration to man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Cotinine, the main metabolite of nicotine, was administered intravenously to healthy male non-smoking volunteers in doses of 5, 10 and 20 mg, and orally in doses of 10 and 20 mg.

Intravenous administration was characterized by a dose-independent half-life of 12.2 h, mean residence time of 15.9 h, total clearance of 3.64 l h−1 and a volume of distribution of 56.5 l. Renal clearance was 0.46 l h−1 and approximately 12.0% of the dose was excreted unchanged in the urine. The mean absorption time after oral dosing ranged between 1 and 3 h, the peak concentration was reached within 45 min and the mean elimination half-lives were 12.9 and 11.7 h, respectively, after the 10 and 20 mg doses. Systemic bioavailability ranged between 0.84 and 1.11 following 10 mg and between 0.97 and 1.03 following the 20 mg dose. Mean urinary recovery and renal clearance were almost identical with the values after iv administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Benowitz NL, Hall SM, Herning RJ, Jacob III P, Jones RT, Osman A-L (1983a) Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 309: 139–142

    Google Scholar 

  • Benowitz NL, Kuyt F, Jacob III P, Jones RT, Osman A-L (1983b) Cotinine disposition and effects. Clin Pharmacol Ther 34: 604–611

    Google Scholar 

  • Bowman ER, Turnbull LB, McKennis H Jr (1959) Metabolism of nicotine in the human and excretion of pyridine compounds by smokers. J Pharmacol Exp Ther 127: 92–95

    Google Scholar 

  • Daenens P, Laruelle L, Callewaert K, De Schepper PJ, Galeazzi R, van Rossum J (1985) Quantitative analysis of cotinine in biological fluids by capillary gaschromatography — mass spectrometry selected ion monitoring. J Chromatogr 342: 79–87

    Google Scholar 

  • Darby TH, McNamee JE, van Rossum JM (1984) Cigarette smoking pharmacokinetics and its relationship to smoking behaviour. Clin Pharmacokinet 9: 435–449

    Google Scholar 

  • Galeazzi RL, Daenens P, Gugger M (1985) Steady-state concentrations of continine as a measure of nicotine intake by smokers. Eur J Clin Pharmacol 28: 301–304

    Google Scholar 

  • Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Marcel Dekker, New York

    Google Scholar 

  • Gori GB, Lynch CJ (1983) Smoker intake from cigarettes in the 1-mg federal trade commission tar class. Reg Toxicol Pharmacol 3: 110–120

    Google Scholar 

  • Greenberg RA, Haley NJ, Etzel RA, Loda FA (1984) Measuring the exposure of infants to tobacco smoke. N Engl J Med 310: 1075–1078

    Google Scholar 

  • Gritz ER, Baer-Weiss V, Benowitz NL, Van Vunakis H, Jarvik ME (1981) Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users. Clin Pharmacol Ther 30: 201–209

    Google Scholar 

  • Hall SM, Herning RI, Jones RT, Benowitz NL, Jacob III P (1984) Blood cotinine levels as indicators of smoking treatment outcome. Clin Pharmacol Ther 35: 810–814

    Google Scholar 

  • Kyerematen GA, Damiano MD, Dvorchik BH, Vesell ES (1982) Smoking-induced changes in nicotine disposition: Application of a new HPLC assay for nicotine and its metabolites. Clin Pharmacol Ther 32: 769–780

    Google Scholar 

  • Langone JJ, Gjika HB, Van Vanukis H (1973) Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry 12: 5025–5030

    Google Scholar 

  • Luck W, Nau H (1984) Nicotine and cotinine concentrations in serum and milk of nursing smokers. Br J Clin Pharmacol 18: 9–15

    Google Scholar 

  • Matsukura S, Sakamoto N, Seino Y, Tamada T, Matsuyama H, Muranaka H (1979) Cotinine excretion and daily cigarette smoking in habituated smokers. Clin Pharmacol Ther 25: 555–561

    Google Scholar 

  • Matsukura S, Taminato T, Kitano N, Seino Y, Hamada H, Uchihashi M, Nakajima H, Hirata Y (1984) Effects of environmental tobacco smoke on urinary cotinine excretion in non-smokers. N Engl J Med 311: 828–832

    Google Scholar 

  • Pilotti A (1980) Biosynthesis and mammalian metabolism of nicotine. Acta Physiol Scand 479 [Suppl]: 13–17

    Google Scholar 

  • Rickert WS, Robinson JC (1981) Estimating the hazards of less hazardous cigarettes II. Study of cigarette yields of nicotine, carbon monoxide, and hydrogen cyanide in relation to levels of cotinine, carboxyhemoglobin, and thiocyanate in smokers. J Toxicol Environ Health 7: 391–403

    Google Scholar 

  • Rosenberg J, Benowitz NL, Jacob III P, Wilson KM (1980) Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther 28: 517–522

    Google Scholar 

  • van Rossum JM, Burgers J, Van Lingen G, De Bie J (1983) Pharmacokinetics: a dynamic systems approach. Tips 4: 27–30

    Google Scholar 

  • Vaughan DP, Dennis M (1978) Mathematical basis of point-area deconvolution method for determining in vivo input functions. J Pharm Sci 67: 663–665

    Google Scholar 

  • Wilcox RG, Hughes J, Roland J (1979) Verification of smoking history in patients after infarction using nicotine and cotinine measurements. Br Med J 2: 1026–1028

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Schepper, P.J., Van Hecken, A., Daenens, P. et al. Kinetics of cotinine after oral and intravenous administration to man. Eur J Clin Pharmacol 31, 583–588 (1987). https://doi.org/10.1007/BF00606635

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00606635

Key words

Navigation